SK BIOPHARMACEUTICALS earnings per share and revenue

326030 earnings per share for the last quarter are 80.57 KRW whereas the estimation was 123.44 KRW which accounts for -34.73% surprise. Company revenue for the same period amounts to 136.60 B KRW despite the estimated figure of 131.49 B KRW. Estimated earnings per share for the next quarter are 197.19 KRW, and revenue is expected to reach 150.34 B KRW. Also watch annual changes over time to get a bigger picture of 326030 earnings per share and revenue dynamics.